Neuroprotective Agents Market, Global Scenario, Market Size, Outlook, Trend, and Forecast, 2016 – 2025

TABLE OF CONTENTS

Chapter 1        Prefix

1.1    Market Scope

1.2    Report Description

1.3    Research Methodology

1.3.1     Primary Research

1.3.2     Secondary Research

1.3.3     In-house Data Modeling

Chapter 2        Executive Summary

2.1   Global Neuroprotective Agents Market Year-on-Year Growth, 2020 – 2028 (%)

Chapter 3        Market Outline

3.1    Market Inclination, Trend, Outlook and Viewpoint

3.2    Market Share Analysis: Company’s Competitive Scenario

3.3    Value Chain Analysis

3.4    Porter’s Five Forces Analysis

3.5    Market Dynamics

3.5.1     Drivers

3.5.1.1     Impact Analysis

3.5.2     Restraints

3.5.2.1     Impact Analysis

3.5.3     Opportunities

Chapter 4        Global Neuroprotective Agents Market by Technology Type: Market Size and Forecast, 2019 – 2028

4.1    Overview

4.2  Therapeutics Agents

4.2.1   Current Trend and Analysis

4.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.3  Regenerative Medicine Products

4.3.1   Current Trend and Analysis

4.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 5        Global Neuroprotective Agents Market: by Therapeutic Indication: Market Size and Forecast, 2019 – 2028

5.1  Overview

5.2  Neuroprotective Agents for Cerebrovascular Technology Type

5.2.1   Current Trend and Analysis

5.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.3  Neuroprotective Agents for Neurodegenerative Disorders

5.3.1   Current Trend and Analysis

5.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.4  Neuroprotective Agents for Ophthalmic Technology Type

5.4.1   Current Trend and Analysis

5.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.4.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.5  Neuroprotective Agents for Traumatic Central Nervous System Injuries

5.5.1   Current Trend and Analysis

5.5.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.5.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.6  Neuroprotective Agents- Based Drug Discovery and Development Industry

5.6.1   Current Trend and Analysis

5.6.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.6.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 6        Global Neuroprotective Agents Market by Geography: Market Size and Forecast, 2019 - 2028

6.1  Overview

6.1.1   Global Neuroprotective Agents Market Year-on-Year Growth, by region 2020 – 2028 (%)

6.2  North America

6.2.1   Current Trend and Analysis

6.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.3   U.S.

6.2.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.3.2        By Technology Type

6.2.3.3        By Therapeutic Indication

6.2.4   Canada

6.2.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.4.2        By Technology Type

6.2.4.3        By Therapeutic Indication

6.2.5   Mexico

6.2.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.5.2        By Technology Type

6.2.5.3        By Therapeutic Indication

6.3    Europe

6.3.1   Current Trend and Analysis

6.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.3   UK

6.3.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.3.2        By Technology Type

6.3.3.3        By Therapeutic Indication

6.3.4   Russia

6.3.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.4.2        By Technology Type

6.3.4.3        By Therapeutic Indication

6.3.5   France

6.3.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.5.2        By Technology Type

6.3.5.3        By Therapeutic Indication

6.3.6   Italy

6.3.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.6.2        By Technology Type

6.3.6.3        By Therapeutic Indication

6.3.7   Germany

6.3.7.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.7.2        By Technology Type

6.3.7.3        By Therapeutic Indication

6.3.8   Rest of Europe

6.3.8.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.8.2        By Technology Type

6.3.8.3        By Therapeutic Indication

6.4    Asia-Pacific

6.4.1   Current Trend and Analysis

6.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.3   China

6.4.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.3.2        By Technology Type

6.4.3.3        By Therapeutic Indication

6.4.4   India

6.4.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.4.2        By Technology Type

6.4.4.3        By Therapeutic Indication

6.4.5   Japan

6.4.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.5.2        By Technology Type

6.4.5.3        By Therapeutic Indication

6.4.6   Rest of Asia-Pacific

6.4.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.6.2        By Technology Type

6.4.6.3        By Therapeutic Indication

6.5    RoW

6.5.1   Current Trend and Analysis

6.5.2   Market Size and Forecast

6.5.3   South America

6.5.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.5.3.2        By Technology Type

6.5.3.3        By Therapeutic Indication

6.5.4   Middle East

6.5.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.5.4.2        By Technology Type

6.5.4.3        By Therapeutic Indication

6.5.5   Africa

6.5.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.5.5.2        By Technology Type

6.5.5.3        By Therapeutic Indication

Chapter 7        Company Profiles

7.1  A B Science

7.1.1     Company Overview

7.1.2     Product Portfolio

7.1.3     Business Strategies

7.1.4     Financials

7.1.5     Recent Developments

7.2  Acucela Inc.

7.2.1     Company Overview

7.2.2     Product Portfolio

7.2.3     Business Strategies

7.2.4     Financials

7.2.5     Recent Developments

7.3  Aerie Pharmaceutical Inc.

7.3.1     Company Overview

7.3.2     Product Portfolio

7.3.3     Business Strategies

7.3.4     Financials

7.3.5     Recent Developments

7.4  Allergan

7.4.1     Company Overview

7.4.2     Product Portfolio

7.4.3     Business Strategies

7.4.4     Financials

7.4.5     Recent Developments

7.5  Astrazeneca Plc

7.5.1     Company Overview

7.5.2     Product Portfolio

7.5.3     Business Strategies

7.5.4     Financials

7.5.5     Recent Developments

7.6  Athersys Inc.

7.6.1     Company Overview

7.6.2     Product Portfolio

7.6.3     Business Strategies

7.6.4     Financials

7.6.5     Recent Developments

7.7  Avexis Inc.

7.7.1     Company Overview

7.7.2     Product Portfolio

7.7.3     Business Strategies

7.7.4     Financials

7.7.5     Recent Developments

7.8  Bayer Healthcare

7.8.1     Company Overview

7.8.2     Product Portfolio

7.8.3     Business Strategies

7.8.4     Financials

7.8.5     Recent Developments

7.9  Biogen Inc.

7.9.1     Company Overview

7.9.2     Product Portfolio

7.9.3     Business Strategies

7.9.4     Financials

7.9.5     Recent Developments

7.10       EISAI Inc.

7.10.1   Company Overview

7.10.2   Product Portfolio

7.10.3   Business Strategies

7.10.4   Financials

7.10.5   Recent Developments